Free Trial

Ono Pharmaceutical (OPHLY) News Today

Ono Pharmaceutical logo
$3.68 -0.09 (-2.39%)
(As of 11/20/2024 ET)
Ono Pharmaceutical Co. Ltd. ADR
ONO PHARMACEUTICAL earnings: here's what Wall Street expects
Ono Pharmaceutical Co., Ltd. (OPHLY)
Ono Pharmaceutical Co. Ltd.
Ono Pharmaceutical earnings preview: what Wall Street is expecting
Nikkei Edges 0.2% Lower Amid JPY Strength
China Shares Open Lower; Infrastructure Stocks Weigh
Twist Bioscience To Develop Novel Antibodies With Ono Pharma
Q2 2023 Fate Therapeutics Inc Earnings Call
Ono Pharmaceutical Co. Ltd ADR (OPHLY)
Here's what to expect from ONO PHARMACEUTICAL's earnings report
Get Ono Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter.

Top "Sleeping Giant" Crypto In The Market Now (Ad)

Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.

Click here to discover our #1 crypto pick before it's too late

OPHLY Media Mentions By Week

OPHLY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPHLY
News Sentiment

0.00

0.47

Average
Medical
News Sentiment

OPHLY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPHLY Articles
This Week

0

0

OPHLY Articles
Average Week

Get Ono Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:OPHLY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners